Antibiotics for treatment of acute respiratory tract infections: Decreasing benefit, increasing risk, and the irrelevance of antimicrobial resistance

Jeffrey A. Linder

doi:10.1086/591149

Antibiotics for treatment of acute respiratory tract infections: Decreasing benefit, increasing risk, and the irrelevance of antimicrobial resistance

Jeffrey A. Linder

Medicine, General Medicine Division

Research output: Contribution to journal › Comment/debate › peer-review

45 Scopus citations

Original language	English (US)
Pages (from-to)	744-746
Number of pages	3
Journal	Clinical Infectious Diseases
Volume	47
Issue number	6
DOIs	https://doi.org/10.1086/591149
State	Published - Sep 15 2008

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1086/591149

Cite this

@article{2ca3a854f7c448d2be1d7d20e91c47f7,

title = "Antibiotics for treatment of acute respiratory tract infections: Decreasing benefit, increasing risk, and the irrelevance of antimicrobial resistance",

author = "Linder, {Jeffrey A.}",

note = "Funding Information: Potential conflicts of interest. J.A.L. has received grant support from Roche and Pfizer.",

year = "2008",

month = sep,

day = "15",

doi = "10.1086/591149",

language = "English (US)",

volume = "47",

pages = "744--746",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Antibiotics for treatment of acute respiratory tract infections

T2 - Decreasing benefit, increasing risk, and the irrelevance of antimicrobial resistance

AU - Linder, Jeffrey A.

N1 - Funding Information: Potential conflicts of interest. J.A.L. has received grant support from Roche and Pfizer.

PY - 2008/9/15

Y1 - 2008/9/15

UR - http://www.scopus.com/inward/record.url?scp=51549115231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51549115231&partnerID=8YFLogxK

U2 - 10.1086/591149

DO - 10.1086/591149

M3 - Comment/debate

C2 - 18694343

AN - SCOPUS:51549115231

SN - 1058-4838

VL - 47

SP - 744

EP - 746

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 6

ER -

Antibiotics for treatment of acute respiratory tract infections: Decreasing benefit, increasing risk, and the irrelevance of antimicrobial resistance

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this